Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
Jonathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Topics & Concepts
VigilMedicineOvarian cancerTerm (time)CancerOncologyInternal medicineSurgeryHistoryPhysicsQuantum mechanicsArchaeologyPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer